ArticleThe American journal of case reports2026
Granulomatosis with Polyangiitis (Wegener Granulomatosis) Presenting as a Pancreatic Mass: A Rare Malignancy Mimic.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Granulomatosis with polyangiitis (GPA), formerly known as Wegener granulomatosis, is a rare autoimmune vasculitis that predominantly affects the respiratory tract and kidneys. Pancreatic involvement is exceedingly uncommon and often misinterpreted as malignancy because of overlapping clinical, radiological, and cytological features. CASE REPORT A 62-year-old man presented with low-grade fever, abdominal bloating, and weight loss for 3 months. Positron emission tomography-computed tomography (PET-CT) revealed a metabolically active mass in the pancreatic body and tail with fluorodeoxyglucose-avid hilar and right cervical lymphadenopathy, raising suspicion of metastatic pancreatic adenocarcinoma. Initial endoscopic ultrasound-guided fine-needle aspiration was interpreted as consistent with well-differentiated adenocarcinoma, representing a false-positive cytologic diagnosis in retrospect, and the patient received 1 cycle of chemotherapy. On referral, systemic evaluation revealed hemoptysis and renal dysfunction, and renal biopsy demonstrated pauci-immune crescentic glomerulonephritis in the setting of high-titer PR3-ANCA positivity, which constituted the decisive diagnostic inflection point overturning the initial malignancy diagnosis. Biopsy from the cervical lump revealed inflamed submandibular gland tissue. A diagnosis of GPA with rare pancreatic involvement was made. The patient responded remarkably to rituximab and corticosteroids, with near-complete disappearance of the pancreatic mass on follow-up imaging. CONCLUSIONS This case exemplifies the diagnostic pitfalls when GPA presents as an isolated pancreatic mass. Fluorodeoxyglucose-PET findings and atypical cytology can mimic adenocarcinoma, leading to inappropriate therapy. Immunologic assays, including C-ANCA, IgG4, and complement levels, alongside histopathological evaluation from multiple sites, are essential for accurate differentiation. Literature review reveals fewer than 15 similar cases, many subjected to unnecessary resections. In patients with systemic features and pancreatic lesions, GPA should be considered a differential diagnosis. Early immunologic testing and multidisciplinary evaluation are key to avoiding misdiagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.